- Home
- Publications
- Publication Search
- Publication Details
Title
The Immune Microenvironment of Breast Cancer Progression
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1375
Publisher
MDPI AG
Online
2019-09-17
DOI
10.3390/cancers11091375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy
- (2019) Avigdor Leftin et al. Scientific Reports
- The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast
- (2019) Julianne M Ubago et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Tumor infiltrating lymphocytes in early breast cancer
- (2018) Giancarlo Pruneri et al. BREAST
- Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ
- (2018) Anthony J. Maxwell et al. EJSO
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients
- (2018) Pablo Mandó et al. OncoTargets and Therapy
- Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling
- (2018) Yan Sun et al. Cell Death & Disease
- Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer
- (2018) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
- (2017) Sathana Dushyanthen et al. Nature Communications
- Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
- (2017) Carlos R. Gil Del Alcazar et al. Cancer Discovery
- Macrophages promote the progression of premalignant mammary lesions to invasive cancer
- (2017) Emily C. Carron et al. Oncotarget
- Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
- (2017) Kylie L. Gorringe et al. Frontiers in Oncology
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
- (2016) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
- (2016) Giancarlo Pruneri et al. BREAST CANCER RESEARCH AND TREATMENT
- Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen
- (2016) Chengcheng Ning et al. CANCER RESEARCH
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
- (2016) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
- (2016) H. Raza Ali et al. PLOS MEDICINE
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration
- (2015) Kingsley O. Osuala et al. BMC CANCER
- Relevance of tumor-infiltrating lymphocytes in breast cancer
- (2015) Sathana Dushyanthen et al. BMC Medicine
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2015) S. Loi et al. CLINICAL CANCER RESEARCH
- Mammary gland development: cell fate specification, stem cells and the microenvironment
- (2015) J. L. Inman et al. DEVELOPMENT
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- Atypical Hyperplasia of the Breast — Risk Assessment and Management Options
- (2015) Lynn C. Hartmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
- (2015) Christine Pasero et al. Oncotarget
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Heterogeneity in the Differentiation and Function of CD8+ T Cells
- (2014) Hans-Willi Mittrücker et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Immune cell quantitation in normal breast tissue lobules with and without lobulitis
- (2014) Amy C. Degnim et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
- (2014) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- B cell Biology: An Overview
- (2014) Hermann Eibel et al. CURRENT ALLERGY AND ASTHMA REPORTS
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- M1 and M2 Macrophages: The Chicken and the Egg of Immunity
- (2014) Charles D. Mills et al. Journal of Innate Immunity
- Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
- (2014) Melinda E Sanders et al. MODERN PATHOLOGY
- The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
- (2014) A. Swierczak et al. Cancer Immunology Research
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- Advantages and clinical applications of natural killer cells in cancer immunotherapy
- (2013) Erik Ames et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
- (2013) Maria Ascierto et al. Journal of Translational Medicine
- Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
- (2012) Leisha A Emens Expert Review of Anticancer Therapy
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- (2012) Timothy O’Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differentiation and gene expression profile of tumor-associated macrophages
- (2012) Astrid Schmieder et al. SEMINARS IN CANCER BIOLOGY
- HIF-1 versus HIF-2 — Is one more important than the other?
- (2012) Agnieszka Loboda et al. VASCULAR PHARMACOLOGY
- Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
- (2011) Makiko Ono et al. BREAST CANCER RESEARCH AND TREATMENT
- Histological, molecular and functional subtypes of breast cancers
- (2011) Gautam K. Malhotra et al. CANCER BIOLOGY & THERAPY
- 2011: the immune hallmarks of cancer
- (2011) Federica Cavallo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
- (2011) P. B. Olkhanud et al. CANCER RESEARCH
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
- (2010) S E Pinder et al. BRITISH JOURNAL OF CANCER
- T regulatory cells and the control of alloimmunity: from characterisation to clinical application
- (2010) Joanna Wieckiewicz et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics
- (2010) Rita A Mukhtar et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Breast cancer precursors revisited: molecular features and progression pathways
- (2010) Maria A Lopez-Garcia et al. HISTOPATHOLOGY
- Leukocytes in Mammary Development and Cancer
- (2010) L. M. Coussens et al. Cold Spring Harbor Perspectives in Biology
- Role of macrophages in tumour progression
- (2009) K.S. Siveen et al. IMMUNOLOGY LETTERS
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
- (2009) Lorraine A. O’ Reilly et al. NATURE
- Pten in stromal fibroblasts suppresses mammary epithelial tumours
- (2009) Anthony J. Trimboli et al. NATURE
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Regulation of In Situ to Invasive Breast Carcinoma Transition
- (2008) Min Hu et al. CANCER CELL
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started